Stay updated on LMB-100 and Pembrolizumab in Mesothelioma Clinical Trial

Sign up to get notified when there's something new on the LMB-100 and Pembrolizumab in Mesothelioma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the LMB-100 and Pembrolizumab in Mesothelioma Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2.
    Difference
    0.0%
    Check dated 2025-05-01T05:54:28.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    The webpage has undergone significant content changes, including the removal of detailed background information on mesothelioma treatments and the addition of a new study location and version revision. The focus has shifted to a specific study involving the drug LMB-100 and pembrolizumab.
    Difference
    56%
    Check dated 2025-04-16T14:48:26.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.3 to version 2.14.4.
    Difference
    0.0%
    Check dated 2025-04-09T09:57:46.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The web page has been updated to version 2.14.3, replacing the previous version 2.14.2.
    Difference
    0.0%
    Check dated 2025-04-01T23:38:57.000Z thumbnail image
  7. Check
    73 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    0.8%
    Check dated 2025-02-24T21:15:48.000Z thumbnail image
  8. Check
    88 days ago
    Change Detected
    Summary
    The web page now includes a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.
    Difference
    0.8%
    Check dated 2025-02-10T10:13:01.000Z thumbnail image

Stay in the know with updates to LMB-100 and Pembrolizumab in Mesothelioma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the LMB-100 and Pembrolizumab in Mesothelioma Clinical Trial page.